[Microdialysis cerebral. Main application of this technique]
- PMID: 11727216
[Microdialysis cerebral. Main application of this technique]
Abstract
Introduction: Microdialysis cerebral technique has been widely employed in order to study the neurotransmitter release.
Development: This technique present numerous advantages such as: allow to work with sample in vivo from animals freely moving, by means of microdialysis can be infused simultaneously different drugs in different points implanted probes in several coordinates; also allow carry out pharmacokinetics studies that show correlation with behavior patter as well as to study metabolic changes, which is not possible when this determination are carry out in tissue, in post mortem stadio.
Conclusions: In the present work is carry out a review about the main results obtaining in the sensitization and abstinence to several drug study and approach to biochemical characteristics to Parkinson s disease (PD) by means of microdialysis technique. In relation to sensibilization studies, the temporal changes in different behavior pattern that modify after amphetamine administration have been studied. Microdialysis study allowed correlationate dopamine concentration with behavior pattern above mentioned. In relation with PD, dopamine concentration after systemic and central (intracerebral) administration of levodopa and another dopaminergic drugs have been studied in different nucleus of basal ganglia as well as its respectively behavior correlates.
Similar articles
-
Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.Neuroscience. 2005;135(3):987-98. doi: 10.1016/j.neuroscience.2005.06.075. Epub 2005 Sep 8. Neuroscience. 2005. PMID: 16154292
-
Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.Funct Neurol. 2000 Oct-Dec;15(4):269-76. Funct Neurol. 2000. PMID: 11213530 No abstract available.
-
Peculiarities of L: -DOPA treatment of Parkinson's disease.Amino Acids. 2005 Mar;28(2):157-64. doi: 10.1007/s00726-005-0162-4. Epub 2005 Mar 9. Amino Acids. 2005. PMID: 15750845 Review.
-
Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.Brain Res Bull. 2006 May 15;69(5):593-6. doi: 10.1016/j.brainresbull.2006.03.001. Epub 2006 Mar 29. Brain Res Bull. 2006. PMID: 16647588
-
Levodopa in the treatment of Parkinson's disease: current controversies.Mov Disord. 2004 Sep;19(9):997-1005. doi: 10.1002/mds.20243. Mov Disord. 2004. PMID: 15372588 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical